Struffert T, Reith W
Klinik für bildgebende Diagnostik und Interventionen, Klinikum Saarbrücken, Germany.
Radiologe. 2002 Nov;42(11):880-4. doi: 10.1007/s00117-002-0818-y.
There is a controversy discussion on screening for aneurysms in risk groups. True guidelines do not exist so far. It seems that screening for familial aneurysms is not advisable today. But adult dominant polycystic kidney disease (ADPKD) patients with a familial history of SAH should be screened because of a high prevalence rate of 25% for intracranial aneurysms in this population. Screening should be performed every 2 to 3 years by MRI angiography in this special risk group.
关于对风险人群进行动脉瘤筛查存在争议性讨论。目前尚无真正的指导方针。如今，对家族性动脉瘤进行筛查似乎并不明智。但是，有蛛网膜下腔出血家族史的成人多囊肾疾病（ADPKD）患者应接受筛查，因为该人群颅内动脉瘤的患病率高达25%。对于这个特殊的风险群体，应每2至3年通过磁共振血管造影进行筛查。
